Price target
20.000.000.00%
The 1 analyst offering 1 year price forecasts for RNAZ have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings to RNAZ in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
RNAZ EPS for the last quarter is −105.93 USD despite the estimation of −105.93 USD. In the next quarter EPS is expected to reach −48.84 USD. Track more of TransCode Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter TransCode Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out TransCode Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, RNAZ price target is 20.00 USD with a max estimate of 20.00 USD and a min estimate of 20.00 USD. Check if this forecast comes true in a year, meanwhile watch TransCode Therapeutics, Inc. stock price chart and keep track of the current situation with RNAZ news and stock market news.